Are you Dr. Blacklow?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 43 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
77 Avenue Louis Pasteur
Boston, MA 02115Phone+1 617-525-4415- Is this information wrong?
Summary
- Dr. Stephen Blacklow, MD is a board certified pathologist in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts and California. He is affiliated with Dana-Farber Cancer Institute and is a Professor of Biological Chemistry and Molecular Pharmacology at Dana-Farber Cancer Institute.
Education & Training
Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1991 - 1995
Harvard Medical SchoolClass of 1991
Certifications & Licensure
CA State Medical License 1997 - 2025
MA State Medical License 1995 - 2024- American Board of Pathology Clinical Pathology
Publications & Presentations
PubMed
- 5 citationsFunctional Comparison between Endogenous and Synthetic Notch Systems.Bassma Khamaisi, Vincent C Luca, Stephen C Blacklow, David Sprinzak> ;ACS Synthetic Biology. 2022 Oct 21
- 5 citationsAffinity-matured DLL4 ligands as broad-spectrum modulators of Notch signaling.David Gonzalez-Perez, Satyajit Das, Daniel Antfolk, Hadia S Ahsan, Elliot Medina, Carolyn E Dundes, Rayyan T Jokhai, Emily D Egan, Stephen C Blacklow, Kyle M Loh, Paul...> ;Nature Chemical Biology. 2023 Jan 1
- 4 citationsPhosphorylation of SHP2 at Tyr62 Enables Acquired Resistance to SHP2 Allosteric Inhibitors in FLT3-ITD-Driven AML.Anamarija Pfeiffer, Giulia Franciosa, Marie Locard-Paulet, Ilaria Piga, Kristian Reckzeh, Vidyasiri Vemulapalli, Stephen C Blacklow, Kim Theilgaard-Mönch, Lars J Jense...> ;Cancer Research. 2022 Jun 6
- Join now to see all
Press Mentions
B SideJanuary 26th, 2021- New Leader of Computational BiomedicineJuly 13th, 2020
Tweaking Mother Nature, Biologists Aim for Better Cancer-Fighting CellsJanuary 28th, 2016
Grant Support
- Structure And Function In Notch SignalingNational Cancer Institute2010–2011
- Medical Scientists Training ProgramNational Institute Of General Medical Sciences2007–2011
- Protein CoreNational Cancer Institute2006–2010
- Oncogenic Notch Signaling: Structural BiologyNational Cancer Institute2006–2010
- Structure And Function In Notch SignalingNational Cancer Institute2002–2010
- Structure And Function In Notch SignalingNational Cancer Institute2008
- Receptor CrystallographyNational Center For Research Resources2006
- Oncogenic Notch Signaling: Structural StudiesNational Cancer Institute2006
- Structure And Function Of The LDL ReceptorNational Heart, Lung, And Blood Institute2002–2006
- High Resolution Structural Studies Of Ligand Binding Domain Of LDL ReceptorNational Center For Research Resources1999–2002
- High Resolution Solution Studies Of Lin 12 Domain Of Human Notch I: LeukemiaNational Center For Research Resources1999–2002
- Folding And Binding Determinants Of The LDL ReceptorNational Heart, Lung, And Blood Institute1998–2001
Hospital Affiliations
Dana-Farber Cancer InstituteBoston, Massachusetts
